
We are seeking a detail-oriented and proactive Sr. Clinical Trial Associate (Sr. CTA) to support the successful execution of clinical studies within Clinical Operations. In this role, you will partner closely with study leads and cross-functional teams to manage key components of clinical trials, ensuring delivery against timelines, budgets, and quality standards.
This is an excellent opportunity for a clinical operations professional who thrives in a fast-paced environment and is eager to contribute to high-impact clinical programs.
Study Team & Meeting Management
Study Documentation, Tracking & Execution
Study Planning & Quality Oversight
Required Qualifications
Preferred Experience & Skills
Deciphera is committed to fair and equitable compensation practices. The base salary pay range for this role is $115,000 - $159,000. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location.
Deciphera believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Deciphera’s competitive total rewards strategy that also includes annual performance bonus, a long-term incentive plan, full range of benefits and other incentive compensation plans (if applicable)
Benefits:
EQUAL EMPLOYMENT OPPORTUNITY INFORMATION
Deciphera is committed to equal employment opportunity and values diversity. To ensure that we comply with reporting requirements, we invite you complete the confidential survey at the end of this application. Providing this information is optional. It will not be accessible or used in the hiring process, and has no effect on your opportunity for employment. This information will also be treated confidentially. We are committed to make all hiring decisions and other employment decisions on a non-discriminatory basis.

As a member of ONO Group, Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.